Venture Assoicates Ii Llcbu... Net Worth

Insiders trading at Neos Therapeutics Inc

Over the last 9 years, insiders at Neos Therapeutics Inc have traded over $796,275 worth of Neos Therapeutics Inc stock and bought 558,630 units worth $7,201,055 . The most active insiders traders include Jack W Schuler, James E Deerfield Mgmt L.P...., and Bryant Fong. On average, Neos Therapeutics Inc executives and independent directors trade stock every 69 days with the average trade being worth of $42,698. The most recent stock trade was executed by Richard I Eisenstadt on 12 December 2018, trading 5,000 units of NEOS stock currently worth $10,800.

What does Neos Therapeutics Inc do?

Neos Therapeutics Inc executives and stock owners

Neos Therapeutics Inc executives and other stock owners filed with the SEC include:

• Gerald McLaughlin,
  President, Chief Executive Officer, Director
• Richard Eisenstadt,
  Chief Financial Officer, Treasurer
• John Limongelli,
  Senior Vice President, General Counsel and Corporate Secretary
• Alan Heller,
  Independent Chairman of the Board
• Linda Szyper,
  Independent Director
• John Schmid,
  Independent Director
• Gregory Robitaille,
  Independent Director
• Bryant Fong,
  Independent Director
• James Robinson,
  Independent Director
• Beth Hecht,
  Independent Director
• Vipin K Garg,
  President, CEO & Director
• Juergen Martens,
  Chief Tech/Operations Officer
• Thomas P Mc Donnell,
  Chief Commercial Officer
• Paul R Edick,
  Director
• Partners 2007, L.P.Presidio...,
  
• Dorothy Engelking,
  VP of Regulatory Affairs
• Mark Tengler,
  Chief Technology Officer
• Ralph Essex Capital Corp Ia...,
  
• Andrew G Delaware Street Ca...,
  
• Jack W Schuler,
  10% owner
• Venture Assoicates Ii Llcbu...,
  
• James E Deerfield Mgmt L.P....,